News

HitGen Ltd announced that the company has entered into a research collaboration with Takeda Pharmaceutical Company Limited to discover novel small molecule leads for multiple targets in…
Read More...

Teva Pharmaceutical announced that it has entered into a definitive agreement under which CooperSurgical will acquire PARAGARD® (intrauterine copper contraceptive), a product within its…
Read More...

Bioverativ and Bicycle Therapeutics announced a research collaboration focused on the discovery, development and commercialization of innovative therapies for hemophilia and sickle cell…
Read More...

Midatech Pharma has announced the submission of a clinical trial application (CTA) for a first in human study of its MTD201 programme in carcinoid cancer and acromegaly. The…
Read More...

Roche announced results from the global phase III ALUR study showing that Alecensa® significantly reduced the risk of disease worsening or death (progression-free survival, PFS) by 85%…
Read More...

Bristol-Myers Squibb Company announced that it has completed the previously announced planned acquisition of IFM Therapeutics. The transaction includes full rights to IFM’s…
Read More...

Project ALS and Amylyx Pharmaceuticals announced a collaboration to undertake pre-clinical studies with Amylyx’s oral compound AMX0035 to advance the understanding of the compound’s…
Read More...

Alcami Corporation announces the formation of a Center of Excellence at its world-class active pharmaceutical ingredient (API) development and manufacturing facility in Germantown,…
Read More...

Immune Therapeutics, Inc., a specialty pharmaceutical company focused on developing and commercializing Lodonal™, its patented, affordable, non-toxic therapy for the management of…
Read More...

Sanofi announced that the U.S. Food and Drug Administration (FDA) granted tentative approval for Admelog® (insulin lispro injection) 100 Units/mL, a rapid-acting human insulin analog.…
Read More...

Labcyte Inc. and SEngine Precision Medicine announced the companies are collaborating to fulfill the promise of personalized medicine by employing Labcyte’s advanced acoustic liquid…
Read More...

The U.S. Food and Drug Administration issued a historic action making the first gene therapy available in the United States, ushering in a new approach to the treatment of cancer and…
Read More...

Alimera Sciences, Inc., a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharmaceuticals, announced that Alimera Sciences…
Read More...

Thermo Fisher Scientific Inc. announced that it has completed its acquisition of Patheon, a leading contract development and manufacturing organization (CDMO) serving the pharmaceutical…
Read More...

Gilead Sciences, Inc. and Kite Pharma, Inc. announced that the companies have entered into a definitive agreement pursuant to which Gilead will acquire Kite for $180.00 per share in…
Read More...

Daiichi Sankyo Company, Limited and Boston Pharmaceuticals, Inc. announced that they have entered into a worldwide licensing agreement for Daiichi Sankyo's novel RET inhibitor, DS-5010.…
Read More...

Kedrion Biopharma and Kamada Ltd., two leading human-derived protein therapeutics companies, announced that KEDRAB™ has received U.S. Food and Drug Administration (FDA) approval for…
Read More...

Genentech, a member of the Roche Group, announced that the U.S. Food and Drug Administration (FDA) has accepted the company’s supplemental Biologics License Application (sBLA) and…
Read More...

Otsuka Pharmaceutical and Mylan have entered into a license agreement between their respective subsidiaries, Otsuka Novel Products GmbH (ONPG) and Mylan Pharmaceuticals Private Limited…
Read More...

Genentech announced that the U.S. Food and Drug Administration (FDA) has accepted the company’s Biologics License Application (BLA) and granted Priority Review for emicizumab…
Read More...